MedTrace Logo

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

NCT03302442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2017-10-05

No results posted yet for this study

Summary

The aim of this observational study is to compare Dimethyl fumarate (DMF) and Teriflunomide on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from French Observatory of Multiple Sclerosis (French MS cohort )

Conditions

  • Relapsing-remitting Multiple Sclerosis

Interventions

OTHER

Non interventional study

Not applicable - Non interventional Study

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2017-08-01
Completion
2017-10-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03302442 on ClinicalTrials.gov